Holen Sie sich die Stockscreener-App
192.08
0.04%
-0.08
Handel nachbörslich:
192.08
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$192.16
Offen:
$192.3
24-Stunden-Volumen:
623.57K
Relative Volume:
0.72
Marktkapitalisierung:
$12.33B
Einnahmen:
$13.84B
Nettoeinkommen (Verlust:
$1.10B
KGV:
18.44
EPS:
10.4185
Netto-Cashflow:
$1.49B
1W Leistung:
+1.20%
1M Leistung:
-3.31%
6M Leistung:
+64.10%
1J Leistung:
+39.29%
1-Tages-Spanne:
$190.43
$193.73
1-Wochen-Bereich:
$186.61
$199.15
52-Wochen-Spanne:
$101.00
$202.69
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
192.08 | 12.33B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
361.32 | 82.55B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
163.01 | 13.96B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
21.79 | 11.83B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
101.11 | 10.32B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
DaVita Inc. (DVA) Announces Ninth Amendment to Credit Agreement - GuruFocus
DaVita Expands Term Loan Facility, Enhancing Capital Flexibility - TipRanks
DavitaEnters Ninth Amendment To Credit Agreement With Jpmorgan On June 8, 2026SEC Filing - TradingView
DaVita Secures $500 Million Incremental Term Loan B-2 Under Credit Facility With JPMorgan - TradingView
DaVita Inc. Enters into Ninth Amendment to Credit Agreement for $500 Million Incremental Tranche B-2 Term Loan - marketscreener.com
DaVita Inc. (DVA) Maintains Strong Buy Rating for 120 Days - GuruFocus
DaVita expands comprehensive kidney care through dialysis services - MSN
Bull of the day: DaVita Inc. (DVA) - MSN
Asset turnover of DaVita Inc. – XETR:TRL - TradingView
Cash per share of DaVita Inc. – XETR:TRL - TradingView
Long term debt to total assets ratio of DaVita Inc. – XETR:TRL - TradingView
EBITDA per share of DaVita Inc. – XETR:TRL - TradingView
DaVita Inc. Cash Flow – XETR:TRL - TradingView
DaVita Inc. Statistics – XETR:TRL - TradingView
Assessing DaVita (DVA) Valuation After Strong Q1 2026 Beat And Upgraded Guidance - Yahoo Finance
Why is DaVita HealthCare Partners stock surging today? - Investing.com
DaVita Inc stock (US23804L1035): Q1 2026 revenue tops estimates while valuation stays in focus - AD HOC NEWS
BofA raises DaVita stock price target to $145 on Q1 beat - Investing.com
DaVita Q1 2026 Earnings: Outpatient and Specialty Care Sector ReviewNews and Statistics - IndexBox
Q1 Earnings Highs And Lows: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
DaVita (DVA) Short Interest & Short Float | Updated Jun 2026 $DVA - MarketBeat
Why is DaVita HealthCare Partners stock surging today? By Investing.com - Investing.com UK
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
The Sound of a Second Chance: DaVita Patients Celebrate Receiving Their Kidney Transplant - DaVita Newsroom
DaVita Expands Comprehensive Kidney Care Through Dialysis Services - Yahoo Finance
DaVita HealthCare (DVA) Up 0.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Best Growth Stocks to Buy for June 4th - Yahoo Finance Singapore
A Look at DaVita Inc (DVA) After 3.8% Gain -- GF Value $172.69 v - GuruFocus
A Look at DaVita Inc (DVA) After 3.8% Gain -- GF Value $172.69 vs Price $195.03 - GuruFocus
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
How The DaVita (DVA) Story Is Shifting With New Analyst Targets And Valuation Assumptions - Yahoo Finance
DaVita Gains 21.4% in Three Months: How Should You Play the Stock? - Yahoo Finance
What are Wall Street analysts' target price for DaVita stock? - MSN
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't - The Motley Fool
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): NYSE-listed dialysis provider trades around late-May levels as inv - AD HOC NEWS
DaVita Inc. (DVA) Stock Analysis: High Return On Equity Highlights Investment Potential - DirectorsTalk Interviews
DaVita Interactive Trivia: Put your knowledge to the test with these questions - Denver7
DaVita Inc stock (US23804L1035): shares ease near late-May levels - AD HOC NEWS
DaVita Inc. stock (US23918K1088): shares ease while investors watch technical levels after recent ga - AD HOC NEWS
DaVita Inc. stock (US23918K1088): NYSE shares hold steady as investors look toward next earnings dat - AD HOC NEWS
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): shares trade sideways ahead of next earnings as valuation comes in - AD HOC NEWS
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term - Yahoo Finance
DaVita (DVA) Revenue BreakdownMain Composition - Moomoo
Two Sides of the "Gift of Life" From DaVita Teammates - ACCESS Newswire
DaVita and Arcosa have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
DaVita Stock Is Up 70% YTD: What the Numbers Say About 2026 - TIKR.com
Bull of the Day: DaVita Inc. (DVA) - Zacks Investment Research
Hope in our Hometown: DaVita Celebrates the 2026 Transplant Games in Denver - DaVita Newsroom
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):